427 related articles for article (PubMed ID: 17727739)
1. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
[TBL] [Abstract][Full Text] [Related]
2. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
[TBL] [Abstract][Full Text] [Related]
3. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
[TBL] [Abstract][Full Text] [Related]
5. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
Evans BK; Kustra RP; Hammer AE
Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
[TBL] [Abstract][Full Text] [Related]
6. Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy.
Stephen LJ; Sills GJ; Leach JP; Butler E; Parker P; Hitiris N; Leach VM; Wilson EA; Brodie MJ
Epilepsy Res; 2007 Jul; 75(2-3):122-9. PubMed ID: 17553671
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy.
Wechsler RT; Leroy R; Van Cott A; Hammer AE; Vuong A; Huffman R; VanLandingham K; Messenheimer JA
Epilepsy Res; 2014 Aug; 108(6):1128-36. PubMed ID: 24888248
[TBL] [Abstract][Full Text] [Related]
9. How to replace lamotrigine with valproate.
Steinhoff BJ
Epilepsia; 2006 Nov; 47(11):1943-4. PubMed ID: 17116036
[TBL] [Abstract][Full Text] [Related]
10. Conversion from immediate-release to extended-release lamotrigine improves seizure control.
Ramey P; Osborn M; Abou-Khalil B
Epilepsy Res; 2014 Nov; 108(9):1637-41. PubMed ID: 25205163
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy.
Gidal BE; Sheth R; Parnell J; Maloney K; Sale M
Epilepsy Res; 2003 Dec; 57(2-3):85-93. PubMed ID: 15013050
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group.
Brodie MJ; Yuen AW
Epilepsy Res; 1997 Mar; 26(3):423-32. PubMed ID: 9127723
[TBL] [Abstract][Full Text] [Related]
14. Prospective study on concentration-efficacy and concentration-toxicity: correlations with lamotrigine serum levels.
Fröscher W; Keller F; Vogt H; Krämer G
Epileptic Disord; 2002 Mar; 4(1):49-56. PubMed ID: 11967180
[TBL] [Abstract][Full Text] [Related]
15. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.
Hirsch LJ; Weintraub D; Du Y; Buchsbaum R; Spencer HT; Hager M; Straka T; Bazil CW; Adams DJ; Resor SR; Morrell MJ
Neurology; 2004 Sep; 63(6):1022-6. PubMed ID: 15452293
[TBL] [Abstract][Full Text] [Related]
16. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
[TBL] [Abstract][Full Text] [Related]
17. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
Jozwiak S; Terczynski A
Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
[TBL] [Abstract][Full Text] [Related]
18. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents.
Mazurkiewicz-Bełdzińska M; Szmuda M; Matheisel A
Seizure; 2010 Apr; 19(3):195-7. PubMed ID: 20167512
[TBL] [Abstract][Full Text] [Related]
20. Effect of comedication on lamotrigine clearance in Korean epilepsy patients.
Kim HJ; Kim TE; Joo EY; Seo DW; Lee SY; Hong SB
Clin Chim Acta; 2015 Jan; 438():269-73. PubMed ID: 25218785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
